– | – | Group 1 Preop Neutral postop Neutral (n = 47) |
Group 2 Preop Varus Postop Neutral (n = 104) |
Group 3 Preop Neutral Postop Malaligned (n = 3) |
Group 4 Preop Varus Postop Malaligned (n = 18) |
p-Value |
---|---|---|---|---|---|---|
HKA | Preoperative | 1.8 ± 1.0 (0.0 – 3.0) | 7.0 ± 2.3 (4.0 – 16.0) | 2.3 ± 0.6 (2.0 – 3.0) | 10.1 ± 3.4 (4.0 – 15.0) | n.r. |
Postoperative | 0.8 ± 1.0 (-2.5 – 2.0) | 1.4 ± 1.0 (-2.0 – 3.0) | 4.7 ± 0.3 (4.5 – 5.0) | 4.3 ± 0.8 (3.5 – 5.5) | n.r. | |
KSS-KS | Preoperative | 24.3 ± 5.0 | 25.2 ± 3.7 | 28.7 ± 3.8 | 26.1 ± 5.0 | 0.186 |
1 year | 89.0 ± 3.4 | 89.4 ± 4.4 | 86.7 ± 9.2 | 88.8± 5.0 | 0.682 | |
2 years | 90.1 ± 4.4 | 90.2 ± 4.9 | 89.0 ± 11.4 | 90.1 ± 5.0 | 0.983 | |
KSS-FS | Preoperative | 20.9 ± 5.6 | 19.7 ± 5.6 | 26.0 ± 8.2 | 21.9 ± 7.0 | 0.093 |
1 year | 87.7 ± 6.2 | 86.9 ± 6.9 | 86.0 ± 7.2 | 87.8 ± 5.8 | 0.872 | |
2 years | 88.6 ± 7.0 | 87.2 ± 7.6 | 90.7 ± 11.4 | 87.4 ± 5.9 | 0.642 | |
WOMAC | Preoperative | 65.4 ± 7.6 | 65.3 ± 5.9 | 62.3 ± 3.5 | 62.8 ± 4.0 | 0.387 |
1 year | 26.2 ± 3.5 | 26.0 ± 4.3 | 24.7 ± 6.4 | 27.5 ± 3.5 | 0.473 | |
2 years | 23.6 ± 3.9 | 23.4 ± 4.9 | 23.0 ± 7.9 | 24.4 ± 3.5 | 0.835 | |
FJS | 2 years | 64.8 ± 7.9 | 63.5 ± 8.6 | 73.0 ± 7.0 | 69.8 ± 7.0 | 0.008 |
HFKS | 2 years | 35.3 ± 5.1 | 35.0 ± 4.9 | 38 ± 5.3 | 39.3 ± 3.4 | 0.005 |
Implant survival at 2 years | Any reason | 100% | 95.2% (95% CI, 88.8 – 98.0%) | 100% | 100% | 0.343 |
Aseptic loosening | 100% | 96.1% (95% CI, 90.0- 98.5%) | 100% | 100% | 0.446 |